| Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix BO Diekman, CR Rowland, DP Lennon, AI Caplan, F Guilak Tissue Engineering Part A 16 (2), 523-533, 2010 | 339 | 2010 |
| The effects of crosslinking of scaffolds engineered from cartilage ECM on the chondrogenic differentiation of MSCs CR Rowland, DP Lennon, AI Caplan, F Guilak Biomaterials 34 (23), 5802-5812, 2013 | 199 | 2013 |
| Fabrication of anatomically-shaped cartilage constructs using decellularized cartilage-derived matrix scaffolds CR Rowland, LA Colucci, F Guilak Biomaterials 91, 57-72, 2016 | 131 | 2016 |
| Regulation of decellularized tissue remodeling via scaffold-mediated lentiviral delivery in anatomically-shaped osteochondral constructs CR Rowland, KA Glass, AR Ettyreddy, CC Gloss, JRL Matthews, ... Biomaterials 177, 161-175, 2018 | 71 | 2018 |
| Meniscus-derived matrix scaffolds promote the integrative repair of meniscal defects JC Ruprecht, TD Waanders, CR Rowland, JF Nishimuta, KA Glass, ... Scientific reports 9 (1), 8719, 2019 | 38 | 2019 |
| Factors influencing the long-term behavior of extracellular matrix-derived scaffolds for musculoskeletal soft tissue repair CR Rowland, D Little, F Guilak Journal of long-term effects of medical implants 22 (3), 2012 | 21 | 2012 |
| Favorable outcomes for patients treated with U2 with co-morbidities or concomitant medications: A retrospective analysis of Unity-CLL phase 3 trial JP Ibarz, W Jurczak, S Kambhampati, EL Maranda, T Wróbel, JP Sharman, ... Blood 138, 3748, 2021 | 4 | 2021 |
| Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma DS Wallace, C Rowland, BT Hill, AM Baran, C Casulo, PM Reagan, ... Leukemia & Lymphoma 64 (9), 1579-1582, 2023 | 1 | 2023 |
| Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia BT Hill, S Ma, CS Zent, AM Baran, DS Wallace, A Advani, A Winter, ... Blood Advances 8 (2), 378-387, 2024 | | 2024 |
| Venetoclax based combination therapy does not overcome poor outcomes in BTKi‐refractory mantle cell lymphoma: phase 2 trial of umbralisib, ublituximab, and venetoclax. DS Wallace, C Rowland, BT Hill, AM Baran, C Casulo, PM Reagan, ... Hematological Oncology 41, 2023 | | 2023 |
| 502. Biomaterial-Mediated Lentiviral Delivery of Anti-Inflammatory Genes in Cartilage-Derived Matrix Hemispheres KA Glass, CR Rowland, AR Ettyreddy, JM Brunger, NPT Huynh, ... Molecular Therapy 24, S199-S200, 2016 | | 2016 |
| Development of Cartilage-Derived Matrix Scaffolds via Crosslinking, Decellularization, and Ice-Templating CR Rowland Duke University, 2015 | | 2015 |
Farshid GuilakOrthopaedic Surgery, Washington University; Shriners Hospitals for Children在 wustl.edu 的电子邮件经过验证
